Actividades psicoterapéuticas dirigidas a la atención hospitalaria de los pacientes pediátricos oncológicos

El cáncer es una de las causas de muerte más habitual por enfermedad en menores. Debido a los grandes avances en la investigación médica y los tratamientos, una gran tasa de niños la supera, de ahí que la promoción, prevención y tratamiento constituye un reto necesario a asumir a partir del análisis de sus dimensiones. El objetivo del trabajo es diseñar un sistema de actividades psicoterapéuticas para el perfeccionamiento de la atención a los pacientes oncológicos en el Hospital Provincial Pediátrico de Camagüey. La metodología empleada fue la cuanticualitativa (análisis de documentos, entrevista, encuestas, observación, entre otros). Se fundamentan teóricamente los elementos conceptuales, se exponen los asuntos psicosociales y didácticos de su diseño, así como la valoración por especialistas. Los resultados introducidos en la práctica desde la Sala de Oncología fueron apreciados favorablemente por los pacientes y familiares en 10 sesiones que incluyeron temas como la autoestima y asertividad.

Cancer is one of the most common causes of death due to illness in children. Due to the great advances in medical research and treatments, a large percentage of children overcome it, hence promotion, prevention and treatment constitute a necessary challenge to assume based on the analysis of its dimensions. The objective of the work is to design a system of psychconapeutic activities to improve care for oncological patients at the Provincial Pediatric Hospital of Camagüey. The methodology used was quantitative (document analysis, interview, surveys, observation, among cons). The conceptual elements are theoretically based, the psychosocial and didactic issues of its design are exposed, as well as the assessment by specialists. The results introduced into practice from the Oncology Ward were favorably appreciated by patients and family members in 10 sessions that included topics such as self-esteem and assertiveness.

Programa de acompañamiento a personas diagnosticadas con cáncer de cabeza y cuello, liderado por la enfermera de práctica avanzada con mención en oncología / Support program for people with head and neck cancer, led by an oncology advanced practice nurse

Se presenta una propuesta de intervención de enfermería de práctica avanzada (EPA) en oncología. OBJETIVO: Implementar un programa de acompañamiento para pacientes con cáncer de cabeza y cuello. PROPUESTA: Realizar un levantamiento del proceso y descripción del flujo que debe transitar el paciente oncológico desde la sospecha, diagnóstico, tratamiento, seguimiento y derivación a cuidados paliativos. En segunda instancia, crear e implementar una consulta de enfermería que pueda responder a las necesidades de atención de salud en forma holística de la persona con diagnóstico oncológico de cáncer de cabeza y cuello, tanto en las personas que se encuentran en fase sospecha y confirmación diagnóstica (consulta de ingreso) y en el proceso de seguimiento del sobreviviente (después de finalizado el tratamiento oncológico), a través de una puesta en marcha escalonada, con períodos de evaluación en cada uno de ellos. CONCLUSIONES: La heterogeneidad de la persona diagnosticada con cáncer de cabeza y cuello representa un desafío y se considera a la EPA un profesional para manejar casos complejos. El camino hacia este nuevo rol será paulatino, y requiere una transición tanto por el equipo de salud, los pacientes y las propias enfermeras dentro del marco legal vigente.

This paper presents a proposal for an advanced practice nursing intervention (APN) in oncology. OBJECTIVE: To implement a support program for patients with head and neck cancer. PROPOSAL: To carry out a survey of the process and description of the flow that the oncology patient must go through from suspicion, diagnosis, treatment, follow-up and referral to palliative care. Secondly, to create and implement a nursing consultation that can respond to the health care needs in a holistic manner of the person with an oncological diagnosis of head and neck cancer, both in people who are in the suspicion and diagnostic confirmation phase (admission consultation) and in the follow-up process of the survivor (after the end of oncological treatment), through a staggered implementation, with evaluation periods in each of them. CONCLUSIONS: The heterogeneity of the person diagnosed with head and neck cancer represents a challenge and the APN is considered a professional to manage complex cases. The journey towards this new role will be gradual, and requires a transition both by the health team, the patients and the nurses themselves within the current legal framework.

Riesgo de mortalidad en infecciones invasoras por Fusarium spp en niños con enfermedades hemato-oncológicas: una revisión sistemática de la literatura / Risk of mortality in invasive infections by Fusarium spp in children with hematooncological diseases: a literature systematic review

INTRODUCCIÓN: Los estudios sobre la infección fúngica invasora (IFI) por Fusarium spp en pacientes pediátricos con patología hemato-oncológica, son escasos, correspondiendo en general a series clínicas descriptas en forma retrospectiva, lo que dificulta conocer en profundidad sus características y evolución. OBJETIVO: Analizar la evolución fatal de la IFI causada por Fusarium spp en pacientes pediátricos con patología hemato-oncológica, llevándose a cabo una revisión sistemática. MATERIAL Y MÉTODOS: La búsqueda bibliográfica se realizó con fecha 23 de marzo de 2023, en las principales bases de datos (Medline (a través de PubMed), Embase (a través de Embase-Elsevier), The Cochrane Library (a través de Wiley), Cinahl (a través de EbscoHOST), SCI-EXPANDED y Scielo (a través de la WOS) y Scopus (a través de Scopus-Elsevier) y libre (mediante el motor Google) y revisando las citas de los artículos incluidos. RESULTADOS: Se rescataron 1.341 artículos, de los cuales se descartaron 931 por diversas razones. Mediante el análisis de los textos completos, finalmente se incluyeron 11 estudios. Todos los estudios eran de nivel 4 (serie de casos). Se detectó una notoria heterogeneidad (p < 0,008) entre los mismos. La mediana de la frecuencia de muerte observada implicó a un tercio de los afectados (Md 33 %; Q1:22,7-Q4:75). CONCLUSIONES: La mortalidad por IFI por Fusarium spp fue alta en niños con patología hemato-oncológica, en especial en aquellos con neutropenia profunda y mala respuesta al tratamiento de su enfermedad de base

BACKGROUND: Studies on invasive fungal infection (IFI) by Fusarium spp in pediatric patients with hemato-oncological pathology are scarce and limited and a few series of cases described retrospectively, which makes it difficult to fully understand their characteristics and outcome. With the aim of analyzing the fatal evolution of these patients, this systematic review was carried out. METHODS: The literature search was performed up to March 23, 2023, in the main databases, as Medline (through PubMed), Embase (through Embase-Elsevier), The Cochrane Library (through Wiley), Cinahl (through EbscoHOST), SCI-EXPANDED and Scielo (through WOS) and Scopus (through Scopus-Elsevier) and free (through the Google engine) and reviewing the citations of the included articles. RESULTS: 1341 articles were retrieved, of which 931 were discarded for various reasons. By analyzing its full texts, 11 studies were finally included. It was observed that heterogeneity among them was relevant (p < 0.008). Median frequency of death involved one third of those affected (Md 33%; Q1:22,7-Q4:75). CONCLUSIONS: Mortality due to IFI due to Fusarium spp was high in children with hemato-oncological pathology, especially in those with severe neutropenia and poor response to treatment of their underlying disease.

Carcinoma sebáceo, 6 años de experiencia en el Instituto Nacional del Cáncer

Objetivo: El carcinoma sebáceo (CS) es una neoplasia infrecuente, de la cual no existen reportes nacionales, ni guías de manejo en Chile. El Instituto Nacional del Cáncer (INC) es un centro de referencia nacional en el manejo de patologías oncológicas; el objetivo de este trabajo es describir la experiencia y tratamiento del carcinoma sebáceo en nuestro centro. Material y Método: Se realizó una revisión retrospectiva, descriptiva, de fichas clínicas entre marzo de 2016 y marzo de 2022 en el INC, en las cuales la biopsia definitiva fuese confirmatoria de CS. Resultados: Se reclutaron 10 pacientes, 6 hombres (60%) y 4 mujeres. Edad promedio fue de 62,9 años ± 18,7 DS. En el 80% de los casos el tumor se encontró en cabeza y cuello y solo 2 casos fueron CS ocular (20%). 4 pacientes tenían asociación al Síndrome de Muir-Torre (SMT) (40%), en el 100% de la muestra se realizó tratamiento quirúrgico con resección oncológica y control de márgenes intraoperatorio, utilizándose en solo 3 casos la técnica Cirugía Micrográfica de Mohs (MMS). En 4 pacientes (40%) se realizó biopsia de linfonodo centinela (BLNC), de los cuales ninguno resulto positivo para metástasis. Ningún paciente presento recidiva local, después de la cirugía y no hubo casos de mortalidad a causa de CS. Ningún paciente recibió radioterapia, quimioterapia o inmunoterapia adyuvante, solo 1 paciente recibió braquiterapia (BT) adyuvante. Conclusión: El CS es una patología compleja e infrecuente, que requiere un tratamiento multidisciplinario y cuyo pilar es la cirugía.

Objective: Sebaceous carcinoma (SC) is an infrequent neoplasm, without national reports nor management guidelines in Chile. National Cancer Institute (NCI) is a reference center for this kind of disease. The aim of this research is to describe the experience and treatment of the sebaceous carcinoma in our center. Methods: A retrospective, descriptive review of clinical records was performed, between March 2016 and March 2022 at the INC, in which the definitive biopsy was confirmatory of CS. Results: A total of 10 patients were enrolled; 6 male (60%) and 4 women. The mean age was 62.9 years ± 18.7 (SD). 80% of the cases were located at the head or the cervical area and only 2 cases were found in the ocular region (20%). Association with SMT (40%) was found in 4 patients. Surgical treatment with oncological resection and intraoperative assessment of margins was performed in 100% of the cases, using MMS technique. Sentinel lymph node biopsy (BLNC) was performed in 4 patients (40%), of which none had metastasis. No patient presented local recurrence after surgery and there were no cases of mortality due to CS. No patient received radiotherapy, chemotherapy or adjuvant immunotherapy. Just 1 received adjuvant brachytherapy. Conclusion: SC is a complex and infrequent disease, which requires multidisciplinary treatment mainly with surgery.

Azul de metileno, opción para la marcación de cáncer colorrectal pre procedimiento mínimamente invasivo. Reporte de caso

El cáncer colorrectal es una patología común que causa aproximadamente 861,000 muertes al año. Se presenta el caso de un paciente masculino de 50 años, con hipertensión arterial y Diabetes mellitus tipo II, con diagnóstico de neoplasia en colon descendente, al cual se le realizó procedimiento mínimamente invasivo, posterior a marcación tumoral con azul de metileno por medio de endoscopia de vías digestiva bajas. Postoperatorio adecuado, sin complicaciones. El tratamiento de elección para el cáncer colorrectal sin metástasis es la exeresis oncológica. Actualmente, el manejo quirúrgico recomendado es por medio de procedimiento mínimamente invasivo, sin embargo, es un desafío puesto que en algunos casos la identificación de la lesión es difícil y adicionalmente requiere una curva de aprendizaje pronunciada. Por lo anterior, utilizamos el azul de metileno para la marcación del tumor previo procedimiento, con excelentes resultados, sin complicaciones. La marcación tumoral con azul de metileno previa al procedimiento mínimamente invasivo es seguro, útil, económico y de bajo riesgo.

Colorectal cancer is a common pathology, causing approximately 861,000 deaths a year. The case a 50-year-old male patient, with arterial hypertension and type II diabetes mellitus, with a diagnosis of neoplasia in the descending colon, which was performed minimally invasive procedure, after tumor marking with methylene blue by means of endoscopy of lower digestive tracts. Adequate postoperative period, without complications. The treatment of choice for colorectal cancer without metastasis is oncological exeresis. Currently the recommended surgical management is by means of a minimally invasive procedure, however, it is a challenge since in some cases the identification of the lesion is difficult and additionally requires a pronounced learning curve. Therefore, we use methylene blue for the marking of the tumor after the procedure, with excellent results, without complications. Methylene blue tumor marking prior to the minimally invasive procedure is safe, useful, inexpensive, and low risk.

Estudo randomizado, aberto, utilizando protetor cutâneo em spray à base de terpolímero acrílico versus hidratante padrão na prevenção de radiodermatite aguda em pacientes com câncer de canal anal e reto / An open randomized study using a skin protector spray made of acrylic terpolymers versus and standardized moisturizer in preventing acute radiodermatitis in patients with anal and rectal cancer

Pacientes com câncer de canal anal e reto em tratamento por radioterapia apresentam alta prevalência de radiodermatite com descamação úmida, desfecho que causa impactos clínicos, econômicos e sociais. Estudos sobre a efetividade de produtos na prevenção das radiodermatites representam uma lacuna de conhecimento na área oncológica, podendo o seu desenvolvimento contribuir para a diminuição dos impactos negativos desse evento, do tempo ocioso do equipamento pela interrupção do tratamento e da possibilidade de falha local da doença. Objetivou-se analisar a efetividade do protetor cutâneo em spray à base de terpolímero acrílico na prevenção da radiodermatite com descamação úmida nos pacientes com câncer de canal anal e reto em comparação com um hidratante padronizado na instituição à base de Calendula officinalis L. e Aloe barbadensis. Ensaio clínico randomizado, aberto, em instituição única, referência nacional no tratamento de doenças oncológicas, com amostra 63 pacientes que foram randomizados nos grupos: experimental, com uso do protetor cutâneo em spray, e controle, usando o hidratante Dnativ Revita Derm. Os pacientes foram acompanhados na consulta de enfermagem, com cegamento do avaliador da pele quanto ao uso da intervenção. A escala de avaliação de pele utilizada foi a da Radiation Therapy Oncology Group. A coleta de dados ocorreu por meio dos formulários de avaliação inicial e subsequente, sendo o desfecho principal medido a ocorrência de radiodermatite com descamação úmida, e os secundários a ocorrência de interrupção temporária da radioterapia por radiodermatite, de eventos adversos aos produtos e de severidade da radiodermatite. As análises se deram por Intenção de Tratar e Protocolo, sendo utilizadas as estatísticas descritiva, analítica e inferenciais no tratamento dos dados, com nível de significância de ≤ 0,10. Pesquisa aprovada pelo Comitê de Ética sob parecer nº 5.322.985 e registrado no Clinical Trials sob número: NCT04067310T. A regressão logística binária mostrou que os participantes expostos ao protetor cutâneo em spray tiveram menor chance de apresentar a radiodermatite com descamação úmida quando comparados ao grupo controle. A redução absoluta do risco de radiodermatite foi de 18% no grupo experimental. A incidência geral de radiodermatite foi de 100%, sendo 36,5% graus mais severos. A incidência de radiodermatite Grau 1 foi maior no grupo experimental, enquanto os graus mais severos (Graus 3 e 4) tiveram maior incidência no grupo controle; 17,5% dos participantes tiveram interrupção da radioterapia por radiodermatite, variando de 3 a 15 dias, com média de seis dias interrompidos. Apesar de relevantes clinicamente, esses resultados sobre a interrupção temporária do tratamento e a severidade da radiodermatite não tiveram significância estatística. Foram considerados fatores de risco para a descamação úmida: sexo feminino, diagnóstico C.21 e C.21.8, altas doses de radioterapia (5400-6000cGy), tipo histológico carcinoma espinocelular, umidade antes e durante a radioterapia e uso de proteção íntima. Concluiu-se que o protetor cutâneo em spray é um produto efetivo na prevenção da radiodermatite com descamação úmida nos pacientes com câncer de canal anal e reto, afirmação que sustenta a tese defendida. Nesse sentido, os resultados podem orientar a revisão dos protocolos assistenciais de prevenção da radiodermatite utilizados pelo enfermeiro no âmbito da consulta de enfermagem em radioterapia, com vistas a reduzir os impactos no seguimento terapêutico e na qualidade de vida dos pacientes com câncer de canal anal e reto.

Patients' ongoing anal and rectal cancer radiotherapy exhibit a high prevalence of radiodermatitis with moist desquamation, impairing clinical, economic, and social outcomes. Clinical trials targeting product efficacy in preventing radiodermatitis are lacking in the current literature. These products could contribute to diminishing adverse effects, reducing equipment idle time by therapy interruption, and increasing the cure rate. Our goal is to evaluate the effectiveness of cutaneous spray based on acrylic terpolymers in preventing radiodermatitis with moist desquamation in patients with rectal or anal cancer. Spray effectiveness was defied against a standardized moisturizer in the institution made of Calendula officinalis L. and Aloe barbadensis extracts. An open, single-blind, randomized clinical study was conducted in a single institution, reference in national treatment in oncological diseases, with a sample size (n) of 63 patients. Patients were randomized into two groups: (i) experimental, using cutaneous protector spray; and (ii) control, using moisturizer Dnativ Revita Derm. RTOC's scale was used for evaluating skin condition. Data was collected in forms, which considered: (i) the primary outcome of radiodermatitis with moist desquamation occurrence; and (ii) the secondary outcome of radiotherapy interruption caused by radiodermatitis occurrence and severity, and product adverse effects. Analyses were performed by intention to treat and per protocol, using descriptive, analytical, and inferential statistics, with a significance level of ≤ 0.10 (α). Research was approved by the Ethics committee under approval nº 5.322.985 and registered in Clinical Trials under number NCT04067310T. Binary logistic regression demonstrated that patients exposed to cutaneous spray protector were less prone to develop radiodermatitis with moist desquamation compared to the control group. Absolute reduction in radiodermatitis risk was 18% in the experimental group. The radiodermatitis overall incidence was 100%, with 36.5% of higher severity. The incidence of grade 1 radiodermatitis was higher in the experimental group, while the more severe grades (3 and 4) had a higher incidence in the control group; 17.5% of the participants had an interruption of radiotherapy due to radiodermatitis, ranging from 3 to 15 days, with an average of six interrupted days. Despite being clinically relevant, these results regarding the temporary interruption of treatment and the severity of radiodermatitis were not statistically significant. Risk factors for moist desquamation were considered: female gender, diagnosis of C.21 and C.21.8, high radiation doses (5400 to 6000 cGy), histological type squamous cell carcinoma, humidity before and during radiotherapy, and use of intimate protection. In conclusion, the skin protector spray is an effective product in the prevention of radiodermatitis with moist desquamation in patients with anal and rectal cancer. In this sense, the results can guide the review of care protocols for the prevention of radiodermatitis used by nurses in the context of nursing consultations in radiotherapy to reduce the impacts on therapeutic follow-up and the quality of life of patients with cancer of the anal canal and straight.

Los pacientes con cáncer de canal anal y recto en tratamiento con radioterapia tienen una alta prevalencia de radiodermatitis con descamación húmeda, desenlace que genera impactos clínicos, económicos y sociales. Los estudios sobre la efectividad de los productos en la prevención de la radiodermatitis representan un vacío de conocimiento en el área de oncología y pueden contribuir para la reducción de los impactos negativos, el tiempo de inactividad de los equipos por interrupción del tratamiento y la posibilidad de falla local de la enfermedad. El objetivo de este estudio fue analizar la eficacia de un protector cutáneo en spray a base de terpolímero acrílico en la prevención de la radiodermatitis con descamación húmeda en pacientes con cáncer anal y rectal frente a una crema hidratante estandarizada de la institución a base de Calendula officinalis L. y Aloe barbadensis. Ensayo clínico aleatorizado, abierto, en una sola institución, referente nacional en el tratamiento de enfermedades oncológicas, con una muestra de 63 pacientes que fueron aleatorizados en grupos: experimental, utilizando spray protector para la piel, y control, utilizando Dnativ Revita Derm hidratante. Los pacientes fueron seguidos en la consulta de enfermería, cegándose el evaluador de piel en cuanto al uso de la intervención. La escala de valoración de la piel utilizada fue la del RTOC. Los datos se recopilaron mediante formularios de evaluación inicial y posterior, siendo el resultado principal medido la aparición de radiodermatitis con descamación húmeda y los resultados secundarios la interrupción temporal de la radioterapia debido a la radiodermatitis, los eventos adversos de los productos y la gravedad de la radiodermatitis. Los análisis fueron realizados por Intención de Tratar y Protocolo, utilizando estadística descriptiva, analítica e inferencial en el procesamiento de datos, con nivel de significación ≤ 0,10. Investigación aprobada por el Comité de Ética con dictamen nº 5.322.985 y registrada en Ensayos Clínicos con el número: NCT04067310T. La regresión logística binaria mostró que los participantes expuestos al protector de piel en aerosol tenían menos probabilidades de tener radiodermatitis con descamación húmeda en comparación con el grupo de control. La reducción absoluta del riesgo de radiodermatitis fue del 18 % en el grupo experimental. La incidencia global de radiodermatitis fue del 100%, siendo el 36,5% grados más graves. La incidencia de radiodermatitis Grado 1 fue mayor en el grupo experimental, mientras que los grados más severos (3 y 4) tuvieron mayor incidencia en el grupo control; El 17,5% de los participantes tuvo interrupción de la radioterapia por radiodermatitis, variando de 3 a 15 días, con un promedio de seis días de interrupción. A pesar de ser clínicamente relevantes, estos resultados en cuanto a la interrupción temporal del tratamiento y la gravedad de la radiodermatitis no fueron estadísticamente significativos. Se consideraron factores de riesgo para descamación húmeda: sexo femenino, diagnóstico C.21 y C.21.8, dosis altas (5400-6000cGy), carcinoma epidermoide de tipo histológico, humedad antes y durante la radioterapia y uso de protección íntima. Se concluyó que el spray protector de piel es un producto eficaz en la prevención de la radiodermatitis con descamación húmeda en pacientes con cáncer anal y rectal, afirmación que sustenta la tesis defendida. En ese sentido, los resultados pueden orientar la revisión de los protocolos de atención para la prevención de la radiodermitis utilizados por los enfermeros en el contexto de las consultas de enfermería en radioterapia, con el objetivo de reducir los impactos en el seguimiento terapéutico y en la calidad de vida de los pacientes con cáncer del canal anal y recto.

Relación interpersonal entre el profesional de enfermería y la persona con un proceso oncológico / Interpersonal relationship between the nursing professional and the person with an oncological condition

INTRODUCCIÓN. La calidad de la interacción humana entre el profesional de la salud y la persona atendida es fundamental en la oncología tanto a nivel ético como práctico. El presente artículo de naturaleza teórica tiene como OBJETIVO: Reflexionar sobre la conceptualización de cómo debe ser la relación interpersonal entre el profesional de enfermería y la persona con un proceso oncológico, es decir, conocer a partir de determinados conceptos su relevancia en el trato humano para una mejor praxis del cuidado de enfermería. METODOLOGÍA: Reflexión teórica basada en conceptos de intersubjetividad y cuidado de enfermería a través de la revisión de literatura. Se enfocará fundamentalmente en el pensamiento de Hildegard E. Peplau dada la relevancia de la visión interactiva - integrativa de su teoría de las relaciones interpersonales como un proceso interpersonal significativo, terapéutico. Asimismo, del Filósofo Martin Heidegger. RESULTADOS: Abordar el cuidado de enfermería bajo la perspectiva de la comprensión del "Ser" con su entorno y no solo el "estar ahí" significa para la persona la importancia del cuidado adecuado en pro de la recuperación, prestando atención empática de las emociones y sentimientos para comprender el sufrimiento del otro y de esta forma se pueda brindar un cuidado significativo. CONCLUSIONES: Los profesionales de enfermería tienen un rol fundamental en la construcción del vínculo terapéutico a través de la relación interpersonal de modo que les permita satisfacer las necesidades de la persona con un proceso oncológico y brindar cuidados significativos de enfermería.

INTRODUCTION. The quality of the human interaction between the health professional and the person being cared for is essential in oncology, both ethically and practically. The present article of theoretical nature has as OBJECTIVE: To reflect on the interpersonal relationship between the nursing professional and the person with an oncological condition, and to examine its relevance in the humane treatment of such persons in the provision of nursing care. METHOD: Theoretical reflection based on concepts of intersubjectivity and nursing care through literature review. It will focus primarily on the concepts of Hildegard E. Peplau, given the relevance of her interactive-integrative vision of interpersonal relationships as key to a meaningful, therapeutic interpersonal process. It also considers the concepts of the philosopher Martin Heidegger. RESULTS: Approaching nursing care from the perspective of understanding the "Being" within its environment, and not only "being there", facilitates recovery. By paying empathic attention to emotions and feelings in an effort to understand the suffering of the other, meaningful care can be provided. CONCLUSIONS: Nursing professionals have a fundamental role in building therapeutic bonds through interpersonal relationships in a way that allows them provide meaningful nursing care to persons with oncologic conditions.

Rehabilitación en cardiotoxicidad relacionada al cáncer

Introducción: La cardiotoxicidad relacionada al cáncer son los efectos nocivos en el corazón ocasionados por el tratamiento oncológico especialmente: agentes de quimioterapia, hormonas, radioterapia y/o inmunoterapia. Objetivos: Realizar una revisión sistemática de la literatura para identificar los efectos secundarios del tratamiento oncológico en el corazón potencialmente prevenibles y susceptibles a tratamiento mediante un programa de rehabilitación cardio-oncológica. Métodos: Se identificaron los estudios relevantes publicados entre el 1° de marzo de 2010 y el 30 de setiembre de 2019 mediante búsqueda en MEDLINE. Resultados: Mediante la prevención , detección temprana de la cardiotoxicidad y la instauración oportuna de un tratamiento cardioprotector se pueden revertir los efectos deletéreos del tratamiento oncológico. Conclusiones: La rehabilitación cardio-oncológica es una estrategia efectiva para mejorar el pronóstico , sobrevida y calidad de vida del paciente con cáncer .

Introduction: Cardiotoxicity is the harmful effect of the oncological treatment on hearth, specially chemotherapy, hormonal treatment , radiotherapy or immunotherapy. Objectives: The objective of this study is to undertake a systematic review of the international scientific literature to identify the effects on hearth which are potencially reversible through cardiac-oncological rehabilitation programmes. Methods: A MEDLINE review of the relevant literature between march 2010 and September 2019. Results: The early detection of cardiotoxicity allows the reversibility of the harmfull effects on hearth. Conclusion: Cardio-oncological rehabilitation is effective in improving prognosis, quality of live and survival on cancer patients.

Anestesia total intravenosa en la cirugía oncológica de mama / Total intravenous anesthesia in oncologist breast surgery

Introducción: El cáncer es la principal causa de muerte. Cada año se diagnostican millones de mujeres con cáncer de mama que necesitan tratamiento quirúrgico, para lo cual la anestesia total intravenosa parece ser una excelente opción. Objetivo: Describir los resultados de la aplicación de la anestesia total intravenosa en las pacientes a las que se les efectuó cirugía oncológica de mama. Métodos: Se realizó un estudio observacional, descriptivo, longitudinal, prospectivo, en el Servicio de Anestesiología del Hospital General Docente "Abel Santamaría Cuadrado" en el período comprendido entre enero de 2013 y enero de 2015. Se estudió una población accesible de 111 pacientes seleccionados mediante criterios de inclusión y exclusión. Para el análisis estadístico se utilizaron distribuciones de frecuencias, cálculo de medidas de tendencia central y de dispersión. Algunas de las variables fueron tensión arterial, frecuencia cardíaca, saturación de oxígeno, complicaciones, tiempo de recuperación, nivel de sedación, respuesta analgésica. Resultados: Se logró gran estabilidad hemodinámica en más del 95 por ciento de las pacientes. Se detectó superficialidad anestésica en 1,80 por ciento de los casos. El 92,80 por ciento de los casos se recuperaron entre 10 y 20 min. Se presentó sedación adecuada en 106 pacientes. Las principales complicaciones fueron las náuseas y los vómitos en 9,01 por ciento. Existió una adecuada respuesta analgésica en 93,69 por ciento de los casos. Conclusiones: La aplicación de la anestesia total intravenosa para cirugía oncológica de mama arrojó resultados muy satisfactorios como método anestésico(AU)

Introduction: Cancer is the leading cause of death worldwide. Every year millions of women are diagnosed with breast cancer and they need surgical treatment, for which total intravenous anesthesia seems to be an excellent option. Objective: Describe the results of the application of total intravenous anesthesia in patients undergoing oncological breast surgery. Methods: An observational, descriptive, longitudinal, prospective study was conducted in the Anesthesiology Service of "Abel Santamaría Cuadrado" Hospital in the period between January 2013 and January 2015. An accessible population of 111 patients selected using inclusion and exclusion criteria was studied. For the statistical analysis, frequency distributions, calculation of measures of central tendency and dispersion were used. Some of the variables were blood pressure, heart rate, oxygen saturation, complications, recovery time, level of sedation, analgesic response. Results: High hemodynamic stability was achieved in more than 95 percent of the patients. Anesthetic superficiality was detected in 1.80 percent of cases. 92.80 percent of the cases recovered after 10 to 20 minutes. Adequate sedation was present in 106 patients. The main complications were nausea and vomiting in 9.01 percent There was an adequate analgesic response in 93.69 percent of the cases. Conclusions: The application of total intravenous anesthesia for oncological breast surgery yielded very satisfactory results as an anesthetic method(AU)

Comunicación de la verdad en oncología desde la visión de la bioética médica / Communication of the truth in oncology from the perspective of medical bioethics

RESUMEN Introducción: La relación médico paciente en oncología se basa en el respeto por la vida, unido de forma constante en la aceptación de la vulnerabilidad y al reconocimiento de la inevitabilidad de la muerte. La comunicación de la verdad, particularmente cuando se trata de informar malas noticias, es una situación estresante, difícil y que demanda la adecuada preparación del personal de la salud. Objetivo: Comentar sobre los fundamentos de la comunicación de la verdad en las enfermedades oncológicas y los puntos relevantes en la relación médico paciente. Desarrollo: Comunicar la verdad entraña varios dilemas éticos en oncología y a veces la información se maneja incorrectamente por el equipo médico. El consenso es no mentir, sin normas rígidas, "ocultar la verdad" y la "conspiración del silencio"; no son del todo errados, el profesional de la salud debe respetar el derecho del paciente de estar informado y a su autonomía, lo que facilitará la toma de decisiones. La relación médico paciente ya cede el terreno a formas más personalistas de relación y el respeto a la libertad individual. Conclusiones: Los fundamentos de la comunicación de la verdad en la enfermedad oncológica, se basan en los principios de la ética y bioética médica, la verdad garantiza una comunicación transparente y enriquecedora. Los puntos relevantes de la RMP consisten en lograr la adecuada alianza terapéutica entre el médico y paciente, en la mejora de su calidad de vida.

ABSTRACT Introduction: The doctor-patient relationship in oncology is based on respect for life, constantly linked to the acceptance of vulnerability and the recognition of the inevitability of death. The communication of the truth, particularly when it comes to reporting bad news, is a stressful and difficult situation that requires the proper preparation of health personnel. Objective: To comment the fundamentals of the communication of the truth in oncological diseases and the relevant points in the doctor-patient relationship. Development: Communicating the truth involves several ethical dilemmas in oncology and sometimes the medical team handles the information incorrectly. The consensus is not to lie, without rigid rules, "hide the truth" and the "conspiracy of silence"; are not entirely wrong, the health professional must respect the patient's right to be informed and their autonomy, which will facilitate decision-making. The doctor-patient relationship is already giving way to more personal forms of relationship and respect for individual freedom. Conclusions: The fundamentals of the communication of the truth in oncological disease are based on the principles of medical ethics and bioethics, the truth guarantees a transparent and enriching communication. The relevant points of the doctor patient relationship consist of achieving the adequate therapeutic alliance between the doctor and the patient, in order to improve their quality of life.

Molecular aspects of Chikungunya virus infections in cancer patients

BACKGROUND Chikungunya virus (CHIKV) is an arbovirus that can cause chronic and debilitating manifestations. The first autochthonous case in Rio de Janeiro state was diagnosed in 2015, and an outbreak was declared in 2016. OBJECTIVE The aim of this work was to evaluate CHIKV viral load in serum, plasma and urine in cancer patients to determine the best sample for diagnosis, as well as perform molecular characterisation and phylogenetic analysis of circulating strains. METHODS Paired serum, plasma and urine collected from 31 cancer patients were tested by real-time quantitative polymerase chain reaction (qPCR) and a segment of the CHIKV E1 gene was sequenced. FINDINGS We detected 11 CHIKV+ oncological patients. Paired samples analyses of nine patients showed a different pattern of detection. Also, a higher viral load in plasma (6.84 log10) and serum (6.07 log10) vs urine (3.76 log10) was found. Phylogenetic analysis and molecular characterisation revealed East/Central/Southern Africa (ECSA) genotype circulation and three amino acids substitutions (E1-K211T, E1-M269V, E1-T288I) in positive patients. MAIN CONCLUSION The results indicate the bioequivalence of serum and plasma for CHIKV diagnosis, with urine being an important complement. ECSA genotype was circulating among patients in the period of the 2016 outbreak with K211T, M269V and T288I substitution.

Impact of the Covid-19 pandemic on colorectal cancer surgery in Madrid

Introduction: The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARSCoV- 2 infection. Methods: In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission). Results: A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p=0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p=0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes. Conclusion: During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid- 19 patients could present a higher morbidity rate. (AU)

Riscos ocupacionais e intervenções que promovem segurança para a equipe de enfermagem oncológica / Occupational risks and interventions to promote safety for oncology nurses

Resumo Objetivo: analisar as evidências científicas relacionadas aos riscos ocupacionais e às intervenções que promovem segurança no trabalho para a equipe de enfermagem oncológica. Métodos: revisão de literatura realizada nas bases de dados MEDLINE, Web of Science, Scopus, LILACS, IBECS e BDENF. Resultados: a busca identificou 17 estudos primários, publicados em inglês, no período de 2008 a 2017. Dentre os fatores que configuram riscos ocupacionais, destacam-se: o déficit no conhecimento; a pouca disponibilidade de equipamentos de proteção individual para manuseio dos medicamentos antineoplásicos; o estresse; e a ansiedade. Quanto às intervenções que promovem a segurança, evidenciam-se: a manutenção do ambiente laboral favorável ao desempenho da assistência; a disponibilidade de insumos; o bom relacionamento interpessoal; a organização do trabalho; o dimensionamento profissional adequado; o conhecimento, a disponibilidade e o incentivo ao uso dos equipamentos de proteção; e a compreensão dos riscos ocupacionais aos quais os profissionais estão expostos. Conclusão: o estudo possibilitou a identificação de fatores associados à atividade laboral que comprometem a saúde da equipe de enfermagem oncológica, demonstrando a necessidade de intervenções voltadas para a melhoria das relações interprofissionais, a capacitação dos profissionais e o oferecimento de um ambiente de trabalho seguro e condições organizacionais que promovam a saúde dos trabalhadores.

Abstract Objective: to analyze scientific evidence on occupational risks and interventions aimed at promoting workplace safety for oncology nurses. Methods: literature review carried out in MEDLINE, Web of Science, Scopus, LILACS, IBECS, and BDENF databases. Results: the search returned 17 primary studies, published in English from 2008 to 2017. The most common factors identified as associated with occupational risks were knowledge deficit, insuficient personal protective equipment (PPE) available for handling anticancer drugs, stress, and anxiety. The interventions identified as promoting occupational safety were: keeping the work environment suitable for care performance; supplies availability; good interpersonal relationship; work organization; suitable professional dimensioning; availability, awareness and encouragement on the use of PPE; and the understanding of the occupational risks to which workers are exposed. Conclusion: the results enable the identification of work-related factors that endanger the oncology nursing teams' health, evincing the need for interventions aimed at improving interprofessional relationships, qualifying professionals, and offering a safe working environment and organizational conditions that will promote workers' health.

Impact of COVID-19 pandemic on care of oncological patients: experience of a cancer center in a Latin American pandemic epicenter / Impacto da COVID-19 sobre o atendimento de pacientes oncológicos: experiência de um centro oncológico localizado em um epicentro Latino-Americano da pandemia

ABSTRACT Objective Since the rising of coronavirus disease 2019 (COVID-19) pandemic, there is uncertainty regarding the impact of transmission to cancer patients. Evidence on increased severity for patients undergoing antineoplastic treatment is posed against deferring oncologic treatment. We aimed to evaluate the impact of COVID-19 pandemic on patient volumes in a cancer center in an epicenter of the pandemic. Methods Outpatient and inpatient volumes were extracted from electronic health record database. Two intervals were compared: pre-COVID-19 (March to May 2019) and COVID-19 pandemic (March to May 2020) periods. Results The total number of medical appointments declined by 45% in the COVID-19 period, including a 56.2% decrease in new visits. There was a 27.5% reduction in the number of patients undergoing intravenous systemic treatment and a 57.4% decline in initiation of new treatments. Conversely, there was an increase by 309% in new patients undergoing oral chemotherapy regimens and a 5.9% rise in new patients submitted to radiation therapy in the COVID-19 period. There was a 51.2% decline in length of stay and a 60% reduction in the volume of surgical cases during COVID-19. In the stem cell transplant unit, we observed a reduction by 36.5% in length of stay and a 62.5% drop in stem cell transplants. Conclusion A significant decrease in the number of patients undergoing cancer treatment was observed after COVID-19 pandemic. Although this may be partially overcome by alternative therapeutic options, avoiding timely health care due to fear of getting COVID-19 infection might impact on clinical outcomes. Our findings may help support immediate actions to mitigate this hypothesis.

RESUMO Objetivo Desde o surgimento da pandemia da doença pelo coronavírus 2019 (COVID-19), há incerteza quanto ao impacto da transmissão para pacientes com câncer. As evidências sobre o aumento da gravidade para pacientes submetidos a tratamento antineoplásico são contra o adiamento do tratamento oncológico. Nosso objetivo foi avaliar o impacto da pandemia de COVID-19 em volumes de pacientes em um centro oncológico, em um epicentro da pandemia. Métodos Os volumes de pacientes ambulatoriais e de internação foram extraídos do banco de dados de prontuários eletrônicos. Dois intervalos foram comparados: períodos pré-COVID-19 (março a maio de 2019) e pandemia COVID-19 (março a maio de 2020). Resultados O número total de consultas médicas diminuiu 45% no período pandemia COVID-19, inclusive com redução de 56,2% nas novas consultas. Houve redução de 27,5% no número de pacientes em tratamento sistêmico intravenoso e de 57,4% no início de novos tratamentos. Por outro lado, ocorreram aumento de 309% em novos pacientes submetidos a regimes de quimioterapia oral e elevação de 5,9% em novos pacientes submetidos à radioterapia no período pandemia COVID-19. Observaram-se queda de 51,2% nos dias de internação e redução de 60% no volume de casos cirúrgicos durante a COVID-19. Na unidade de transplante de células-tronco, a redução foi de 36,5% nos dias de internação e de 62,5% nos transplantes de células-tronco. Conclusão Foi observado declínio significativo no número de pacientes em tratamento de câncer após a pandemia de COVID-19. Embora isso possa ser parcialmente superado por opções terapêuticas alternativas, evitar cuidados de saúde oportunos devido ao medo de contrair COVID-19 pode impactar nos resultados clínicos. Nossos resultados podem ajudar a apoiar ações imediatas para mitigar essa hipótese.

《2020 ESC/HFA Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies》: What is new? / 中华检验医学杂志

Detection of serum biomarkers is an important strategy for the diagnosis of cardiovascular diseases. The roles of serum biomarker detection have become increasingly valuable in the baseline risk stratification among cancer patients in recent years. The Cardio-oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology newly proposed the “role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies”. By evaluating the characteristics of cardiac biomarkers in cancer patients receiving cardiotoxic cancer therapy, this statement discussed the mechanism, clinical application, value on monitoring and prognosis of the two main biomarkers,cardiac troponin and natriuretic peptide on chemotherapy induced cardiac toxic responses. The purpose of this statement is to help establish the multidisciplinary collaborative diagnosis and treatment strategies and provide a clinical framework, and guide clinicians to select appropriate serum biomarker monitoring programs based on risk stratification to prevent cardiovascular disease in cancer patients.

Practice and exploration of online teaching of oncological radiotherapy during standardized residency training / 中华医学教育探索杂志

This study takes the online teaching of oncological radiotherapy for standardized residency training in Harbin Medical University Cancer Hospital as an example, interprets the practice of carrying out online education, thinks about the problems in the teaching process, and is committed to making great contributions to the improvement of medical education quality in the new era and new background.

New trends worthy of attention in lung cancer surgery / 中国胸心血管外科临床杂志

@#(1) Surgery is the first method to cure early stage non-small cell lung cancer (NSCLC). Ground glass nodule (GGO) like lung adenocarcinoma should be regarded as a new clinical issue to avoid over-treatment. The deep meaning of multidisciplinary pathological classification of lung adenocarcinoma should be fully understood to avoid over-diagnosis. The T staging of lung adenocarcinoma mixed with GGO components should be correctly understood to avoid over-staging. We should carefully understand the new data of relationship between sublobectomy and prognosis to avoid excessive resection. Attention should be paid to the research progress of minimal residual disease (MRD) to avoid insufficient treatment. (2) The treatment strategy of resectable stage Ⅲ NSCLC should be surgery with individualized systemic treatment. Locally advanced NSCLC dominated by Ⅲa-N2 NSCLC is a kind of disease with high multi-dimensional heterogeneity. In theory, preoperative treatment is superior to postoperative treatment, and molecular diagnosis should be made along with pretreatment staging, so as to select preoperative treatment. The patients with negative driver gene mutation obtained better pathological complete response/major pathological response (PCR/MPR) from immunotherapy compared to those from chemotherapy, and the better PCR/MPR is expected to be transformed into overall survival (OS). The data of preoperative treatment in patients with positive driver gene mutation are few, whereas the data of postoperative targeted treatment are much better than those of postoperative chemotherapy. (3) The effective systemic treatment strategy has "created" many long-term survivors with stage Ⅳ NSCLC, and has changed the original concept and population of "oligometastasis". Attention should be paid to the individual ineffective lesions in stage Ⅳ patients with long-term survival. It is also necessary to explore how to intervene in the resection of "oligometastasis" of stage Ⅳ NSCLC at an appropriate time and in an appropriate way, which may be one of the main tasks of lung cancer surgery in the future.

Espiritualidad en el contexto de cuidados paliativos oncológicos dirigidos a personas mayores / Spirituality in palliative care aimed at the elderly / Espiritualidade no contexto de cuidados paliativos oncológicos a idosos

Resumen La última década ha estudiado la faceta "espiritualidad" en el contexto de cuidados paliativos oncológicos en personas mayores desde perspectivas cuantitativas, cualitativas y mixtas. El estudio busca develar -en este contexto- el significado de espiritualidad. Se revisa literatura indexada en buscador PubMed vía Medline entre los años 2009 y 2019, con acceso on line, a texto completo, en forma anónima, en idiomas inglés-español y, análogamente, con búsqueda manual en la Revista Medicina Paliativa. Los resultados arrojan 50 artículos de pertinencia temática y cuatro categorías. Se concluye que existen desafíos relacionados con el significado de espiritualidad y calidad de vida, formación y perspectivas de investigación.

Abstract In the last decade, spirituality has been studied in oncological palliative care for the elderly from quantitative, qualitative, and mixed perspectives. The study seeks to reveal the meaning of spirituality in this context. It reviews indexed literature from the MEDLINE database through PubMed between 2009 and 2019, which was accessed online, in full text, anonymously, and in English and Spanish. Revista Medicina Paliativa was manually searched. The results include 50 subject-relevant articles and four categories. It is concluded that there are challenges related to the meaning of spirituality and quality of life, education, and research perspectives.

Resumo Na última década, a faceta "espiritualidade" tem sido estudada no contexto de cuidados paliativos oncológicos a idosos sob perspectivas quantitativa, qualitativa e mista. O estudo pretende revelar o significado de espiritualidade nesse âmbito. A literatura indexada no buscador PubMed via Medline entre 2009 e 2019 é revisada, por meio do acesso on-line dos textos completos, de forma anônima, em inglês e espanhol, além da busca manual na Revista Medicina Paliativa. Os resultados demonstram 50 artigos de pertinência temática e quatro categorias. Conclui-se que existem desafios relacionados com o significado de espiritualidade e qualidade de vida, formação e perspectivas de pesquisa.

Altura del tumor en el cáncer de recto: resultados postoperatorios y oncológicos en cirugía laparoscópica / Tumor height in rectal cancer: oncological and post surgery results in laparoscopic surgery

RESUMEN Existe pobre evidencia del impacto de la altura de los tumores de recto extraperitoneal en los resultados postoperatorios y oncológicos. No obstante, se ha reportado que aquellos tumores de recto inferior tendrían peor pronóstico oncológico y mayor tasa de complicaciones. Sin embargo, se desconoce si la laparoscopía podría disminuir dichas dificultades en tumores bajos. El objetivo de este trabajo fue revisar artículos bibliográficos actualizados relacionados con los tumores de recto extraperitoneal y los resultados utilizando un abordaje laparoscópico. Se incluyeron 22 artículos sobre tumores de recto extraperitoneal operados por vía laparoscópica. Se compararon variables demográficas, resultados quirúrgicos, histopatológicos y oncológicos entre los artículos revisados. No hubo diferencias en variables demográficas en la revisión. La incidencia de complicaciones tempranas fue muy baja y las complicaciones tardías fueron más anatomopatológicas (escisión total del mesorrecto, margen de resección circunferencial). Las variables y estadios patológicos no presentaron diferencias. Con una mediana de seguimiento de 41,8 meses (rango: 6-120), las tasas de recurrencia y sobrevida fueron comparables. La altura de los tumores de recto extraperitoneal no afectaría los resultados quirúrgicos ni oncológicos en la escisión total del mesorrecto laparoscópica (AU).

SUMMARY There is little evidence of the impact of the extra peritoneal rectal tumors height in the oncological and post surgery results. Nevertheless, it has been reported that inferior rectal tumors would have a worse oncological prognosis and a bigger rate of complications. But it is unknown if laparoscopy could reduce those difficulties in low tumors. The aim of this work was reviewing up-dated bibliographic articles dealing with tumors of the extra peritoneal rectum and the results obtained using a laparoscopic approach. 22 articles on tumors of extra peritoneal rectum that underwent laparoscopic surgery were included. Demographic variables and oncological, histopathologic surgical results were compared between the reviewed articles. Differences in demographic variables were not found in the review. The incidence of early complications was low and late complications were more anatomopathologic ones (total mesorectal resection, circumferential resection margin). Variables and pathological stages did not show differences. With an average follow up of 41.8 months (range 6-120), the recurrence rates and survival were similar. The height of extra peritoneal rectum tumors would not affect surgical nor oncologic results in the total laparoscopic mesorectal resection (AU).